- In January 2020, Janssen Pharmaceuticals, Inc,. submitted a Type II Varian Application for SPRAVATO nasal spray to the European Medicines Agency. The proposal requests that nasal spray be used more widely as an acute, short-term therapy for depression symptoms. This would assist the business in generating revenue.
Frequently Asked Questions
The market is segmented based on U.S. Psychedelic Drugs Market Segmentation, By Source (Synthetic, Natural), Type (Empathogens, Dissociatives, Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End-User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2032
.
The Us Psychedelic Drugs Market size was valued at USD 4.51 USD Billion in 2024.
The Us Psychedelic Drugs Market is projected to grow at a CAGR of 16.8% during the forecast period of 2025 to 2032.
The market report covers data from the U.S..
